SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-010177
Filing Date
2024-01-18
Accepted
2024-01-18 16:02:53
Documents
13
Period of Report
2024-01-18
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d695291d8k.htm   iXBRL 8-K 29253
2 EX-99.1 d695291dex991.htm EX-99.1 10810
  Complete submission text file 0001193125-24-010177.txt   163862

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20240118.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20240118_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20240118_pre.xml EX-101.PRE 10808
7 EXTRACTED XBRL INSTANCE DOCUMENT d695291d8k_htm.xml XML 3230
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 24541775
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)